156 related articles for article (PubMed ID: 18220583)
1. Oxidative stress and the JNK pathway in diabetes.
Kaneto H; Matsuoka TA; Nakatani Y; Kawamori D; Matsuhisa M; Yamasaki Y
Curr Diabetes Rev; 2005 Feb; 1(1):65-72. PubMed ID: 18220583
[TBL] [Abstract][Full Text] [Related]
2. Role of oxidative stress in pancreatic beta-cell dysfunction.
Kajimoto Y; Kaneto H
Ann N Y Acad Sci; 2004 Apr; 1011():168-76. PubMed ID: 15126294
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress and pancreatic beta-cell dysfunction.
Kaneto H; Kawamori D; Matsuoka TA; Kajimoto Y; Yamasaki Y
Am J Ther; 2005; 12(6):529-33. PubMed ID: 16280646
[TBL] [Abstract][Full Text] [Related]
4. Involvement of oxidative stress in the pathogenesis of diabetes.
Kaneto H; Katakami N; Kawamori D; Miyatsuka T; Sakamoto K; Matsuoka TA; Matsuhisa M; Yamasaki Y
Antioxid Redox Signal; 2007 Mar; 9(3):355-66. PubMed ID: 17184181
[TBL] [Abstract][Full Text] [Related]
5. The JNK pathway as a therapeutic target for diabetes.
Kaneto H
Expert Opin Ther Targets; 2005 Jun; 9(3):581-92. PubMed ID: 15948675
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress and the JNK pathway as a potential therapeutic target for diabetes.
Kaneto H; Kawamori D; Nakatani Y; Gorogawa S; Matsuoka TA
Drug News Perspect; 2004 Sep; 17(7):447-53. PubMed ID: 15514704
[TBL] [Abstract][Full Text] [Related]
7. Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression.
Kaneto H; Xu G; Fujii N; Kim S; Bonner-Weir S; Weir GC
J Biol Chem; 2002 Aug; 277(33):30010-8. PubMed ID: 12011047
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes.
Kaneto H; Matsuoka TA; Nakatani Y; Kawamori D; Miyatsuka T; Matsuhisa M; Yamasaki Y
J Mol Med (Berl); 2005 Jun; 83(6):429-39. PubMed ID: 15759102
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress and the JNK pathway are involved in the development of type 1 and type 2 diabetes.
Kaneto H; Matsuoka TA; Katakami N; Kawamori D; Miyatsuka T; Yoshiuchi K; Yasuda T; Sakamoto K; Yamasaki Y; Matsuhisa M
Curr Mol Med; 2007 Nov; 7(7):674-86. PubMed ID: 18045145
[TBL] [Abstract][Full Text] [Related]
10. Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic beta-cell dysfunction and insulin resistance.
Kaneto H; Nakatani Y; Kawamori D; Miyatsuka T; Matsuoka TA; Matsuhisa M; Yamasaki Y
Int J Biochem Cell Biol; 2005 Aug; 37(8):1595-608. PubMed ID: 15878838
[TBL] [Abstract][Full Text] [Related]
11. Involvement of oxidative stress and the JNK pathway in glucose toxicity.
Kaneto H; Nakatani Y; Kawamori D; Miyatsuka T; Matsuoka TA
Rev Diabet Stud; 2004; 1(4):165-74. PubMed ID: 17491701
[TBL] [Abstract][Full Text] [Related]
12. Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic beta-cell dysfunction and insulin resistance.
Kaneto H; Nakatani Y; Kawamori D; Miyatsuka T; Matsuoka TA; Matsuhisa M; Yamasaki Y
Int J Biochem Cell Biol; 2006; 38(5-6):782-93. PubMed ID: 16607699
[TBL] [Abstract][Full Text] [Related]
13. The forkhead transcription factor Foxo1 bridges the JNK pathway and the transcription factor PDX-1 through its intracellular translocation.
Kawamori D; Kaneto H; Nakatani Y; Matsuoka TA; Matsuhisa M; Hori M; Yamasaki Y
J Biol Chem; 2006 Jan; 281(2):1091-8. PubMed ID: 16282329
[TBL] [Abstract][Full Text] [Related]
14. Glucose-Induced β-Cell Dysfunction In Vivo: Evidence for a Causal Role of C-jun N-terminal Kinase Pathway.
Tang C; Yeung LSN; Koulajian K; Zhang L; Tai K; Volchuk A; Giacca A
Endocrinology; 2018 Nov; 159(11):3643-3654. PubMed ID: 30215691
[TBL] [Abstract][Full Text] [Related]
15. Human high-density lipoprotein particles prevent activation of the JNK pathway induced by human oxidised low-density lipoprotein particles in pancreatic beta cells.
Abderrahmani A; Niederhauser G; Favre D; Abdelli S; Ferdaoussi M; Yang JY; Regazzi R; Widmann C; Waeber G
Diabetologia; 2007 Jun; 50(6):1304-14. PubMed ID: 17437081
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-125b-5p improves pancreatic β-cell function through inhibiting JNK signaling pathway by targeting DACT1 in mice with type 2 diabetes mellitus.
Yu CY; Yang CY; Rui ZL
Life Sci; 2019 May; 224():67-75. PubMed ID: 30684546
[TBL] [Abstract][Full Text] [Related]
17. Branched-chain amino acids supplementation protects streptozotocin-induced insulin secretion and the correlated mechanism.
Lu M; Zhang X; Zheng D; Jiang X; Chen Q
Biofactors; 2015; 41(2):127-33. PubMed ID: 25359484
[TBL] [Abstract][Full Text] [Related]
18. Involvement of oxidative stress-induced ERK/JNK activation in the Cu(2+)/pyrrolidine dithiocarbamate complex-triggered mitochondria-regulated apoptosis in pancreatic β-cells.
Wu CC; Yen CC; Lee kI; Su CC; Tang FC; Chen KL; Su YC; Chen YW
Toxicol Lett; 2012 Feb; 208(3):275-85. PubMed ID: 22085843
[TBL] [Abstract][Full Text] [Related]
19. Activation of the hexosamine pathway leads to deterioration of pancreatic beta-cell function through the induction of oxidative stress.
Kaneto H; Xu G; Song KH; Suzuma K; Bonner-Weir S; Sharma A; Weir GC
J Biol Chem; 2001 Aug; 276(33):31099-104. PubMed ID: 11390407
[TBL] [Abstract][Full Text] [Related]
20. Acute oxidative stress can reverse insulin resistance by inactivation of cytoplasmic JNK.
Berdichevsky A; Guarente L; Bose A
J Biol Chem; 2010 Jul; 285(28):21581-9. PubMed ID: 20430894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
